This content is machine translated News from nephrology Renal insufficiency and hypertension Chronic kidney disease (CKD) is classified according to the type of underlying disease, filtration rate and extent of proteinuria. Patients with CKD are cardiovascular risk patients. Cardiovascular morbidity increases with…
View Post 3 min This content is machine translated ARUBA study Drug therapy continues to perform better A new extrapolation on the ARUBA trial shows that the benefit of simple drug therapy over intervention in patients with asymptomatic arteriovenous malformations may last much longer than originally thought.
View Post 4 min This content is machine translated Diabetes, hypertension and stable CHD The latest guidelines of the European Society of Cardiology In 2013, the European Society of Cardiology (ESC) published new guidelines on various cardiovascular diseases. These were presented in a Main Session at the Annual Meeting of the Swiss Society…
View Post 5 min This content is machine translated TAVI From good to better At the first Scientific Session of the Annual Meeting of the Swiss Society of Cardiology on June 11, 2014, the focus was on TAVI (transcatheter aortic valve implantation). Cardiac surgeons…
View Post 7 min This content is machine translated Nutrition in cardiovascular diseases Do food additives lower the risk of heart attack? One of the workshops at the annual meeting of the Swiss Society of Cardiology on June 12, 2014, examined the role of diet in cardiovascular disease. How do alcohol, omega-3…
View Post 8 min This content is machine translated Congress of the European Society of Hypertension (ESH) Fat people think faster Dozens of new study results were presented at this year’s European Society of Hypertension (ESH) and International Society of Hypertension Congress in Athens. The focus was not only on high…
View Post 4 min This content is machine translated Metastatic colorectal cancer Comparison between bevacizumab and cetuximab in KRAS exon2 wild type. According to preliminary results of a large phase III trial presented at this year’s ASCO congress, bevacizumab and cetuximab (combined with FOLFOX or FOLFIRI) show similar efficacy in terms of…
View Post 4 min This content is machine translated Immuno-Oncology New pathways for improved cancer treatment? Long-term survival of patients with advanced-stage carcinoma is still an area where research is far from successful. In the field of melanoma, the approval of ipilimumab in 2011 has made…
View Post 4 min This content is machine translated Hype or hope? Metformin, vitamin D and aspirin as anticancer agents Time and again, various substances are praised as “anticancer agents,” both in scientific circles and in the lay press. A symposium at this year’s ASCO Congress in Chicago was dedicated…
View Post 5 min This content is machine translated Myeloproliferative neoplasms News from a field that is developing rapidly Classic myeloproliferative neoplasms (MPNs) include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Several sessions at the EHA Congress in mid-June addressed the revision in the guidelines, news on JAK inhibition,…
View Post 6 min This content is machine translated Tumors in the head and neck area What does HPV infection mean for treatment? The incidence of tumors in the head and neck region is increasing. This is often caused by infections with the human papilloma virus 16 (HPV16). However, the prognosis of patients…
